Literature DB >> 308183

Cellular immunity in Guamanians with amyotrophic lateral sclerosis and Parkinsonism-dementia.

P M Hoffman, D S Robbins, M T Nolte, C J Gibbs, D C Gajdusek.   

Abstract

To test the hypothesis that host resistance factors may be abnormal in Guamanians in whom amyotrophic lateral sclerosis and Parkinsonism-dementia develop, cellular immunity was evaluated in both diseases and compared to that of Guamanians with other nervous-system diseases, normal adult Guamanians and non-Guamanians with amyotrophic lateral sclerosis and Parkinsonism. Diminished responses to skin-test antigens, lymphopenia, diminished per cent and total T cells and, less frequently, decreased mitogen responses were seen in Guamanian patients with amytorophic lateral sclerosis and Parkinsonism-dementia but not in the other patient or normal groups. Guamanian patients with amyotrophic lateral sclerosis and diminished cellular immunity had an increased frequency of HLA-Bw35 (P less than 0.005) and shorter mean duration of disease (P less than 0.05) than those with normal cellular immunity. In Parkinsonism dementia diminished cellular immunity was less strongly associated with HLA-BW35 (P less than 0.05) and was not associated with differences in duration of disease. Normal Guamanians and those with other nervous-system diseases showed no association of diminished cellular immunity with HLA-Bw35. The association appeared disease-related, with onset concomitant with the neurologic expression of Guamanian amyotrophic lateral sclerosis and Parkinsonism-dementia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308183     DOI: 10.1056/NEJM197809282991302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  10 in total

Review 1.  Immunology of amyotrophic lateral sclerosis.

Authors:  N R Cashman; M E Gurney; J P Antel
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis.

Authors:  T L Roszman; R J Cross; W H Brooks; W R Markesbery
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

3.  Hypothalamic-immune interactions: neuromodulation of natural killer activity by lesioning of the anterior hypothalamus.

Authors:  R J Cross; W R Markesbery; W H Brooks; T L Roszman
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

4.  DAT and TH expression marks human Parkinson's disease in peripheral immune cells.

Authors:  Adithya Gopinath; Phillip Mackie; Basil Hashimi; Anna Marie Buchanan; Aidan R Smith; Rachel Bouchard; Gerry Shaw; Martin Badov; Leila Saadatpour; Aryn Gittis; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Parastoo Hashemi; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2022-06-07

5.  Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens.

Authors:  H Bartfeld; C Dham; H Donnenfeld; L Jashnani; R Carp; R Kascsak; J Vilcek; M Rapport; S Wallenstein
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

Review 6.  TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

Authors:  Meredith C Hermosura; Ralph M Garruto
Journal:  Biochim Biophys Acta       Date:  2007-02-24

7.  Motor neurone disease and hyperthyroid Graves' disease: a chance association?

Authors:  J McMenamin; M Croxson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-01       Impact factor: 10.154

8.  CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.

Authors:  Jessica A Hutter Saunders; Katherine A Estes; Lisa M Kosloski; Heather E Allen; Kathryn M Dempsey; Diego R Torres-Russotto; Jane L Meza; Pamela M Santamaria; John M Bertoni; Daniel L Murman; Hesham H Ali; David G Standaert; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-11       Impact factor: 4.147

Review 9.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

10.  Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Authors:  Rebecca Banerjee; R Lee Mosley; Ashley D Reynolds; Alok Dhar; Vernice Jackson-Lewis; Paul H Gordon; Serge Przedborski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.